Your cholesterol is high. You're young. Here's the biological reason.

Your LDL receptor is like a doorway on the surface of every cell in your body. LDL cholesterol particles circulate in your blood, and when they encounter this doorway, they lock on and get pulled inside the cell. Once inside, the cell uses that cholesterol for building cell membranes and making hormones. The doorway gets recycled back to the cell surface. It’s an elegant system that keeps cholesterol levels in balance.

When you carry pathogenic variants in the LDLR gene, those doorways don’t work properly. You might have fewer of them. Or they might malfunction. Familial hypercholesterolemia, the condition caused by LDLR variants, affects roughly 1 in 300 people in the general population. People with pathogenic LDLR variants can have LDL cholesterol levels two to ten times higher than normal, even in childhood.

If you have an LDLR variant, you’ve probably noticed this your whole life. Your cholesterol was always high, even as a kid. Your parents’ cholesterol was high too, though they might not have known it was genetic. Every cell in your body is essentially starved for that doorway mechanism. Your liver ramps up cholesterol production to compensate, flooding your bloodstream with more particles than your cells can handle.

ApoB is the protein shell of every LDL particle. It’s the tag that says, ‘Hey, LDL receptor, grab me.’ Without functional ApoB, your LDL particles drift around in your bloodstream invisible to the very receptors designed to pull them out of circulation. Your cells don’t recognize these particles, so they never get removed.

Pathogenic variants in the APOB gene, particularly R3527Q, create defective ApoB that can’t bind effectively to the LDL receptor. This variant causes familial defective apoB, a condition that accounts for roughly 5% of familial hypercholesterolemia cases. Even though your LDL receptors are working perfectly, the particles they’re supposed to grab are essentially unrecognizable.

You get the same result as LDLR dysfunction: sky-high LDL cholesterol that diet can’t touch. But the mechanism is different. Your cells have plenty of doorways. The doorways are in perfect working order. The problem is that the particles knocking on the door can’t be recognized. It’s like your cells are waiting for a guest to arrive, and the guest is wearing a mask that makes them unrecognizable.

PCSK9 is a protein that hunts down LDL receptors and destroys them. It’s a quality-control system gone haywire. Normally, PCSK9 removes a small number of damaged receptors from the cell surface to keep the system running smoothly. But when you carry a gain-of-function variant in PCSK9, the protein becomes overactive. It destroys receptors faster than your cells can rebuild them.

Gain-of-function PCSK9 variants are relatively rare, found in roughly 1-3% of the population, but when present they’re powerful drivers of high cholesterol. A hyperactive PCSK9 variant can reduce the number of functional LDL receptors on your cells by 50% or more, causing LDL cholesterol to soar even if your LDLR and APOB genes are perfectly normal.

You experience this as cholesterol that shoots upward despite diet and exercise. A standard statin works partly by telling your cells to make more LDL receptors to compensate for the ones destroyed. But if PCSK9 is destroying them faster than your cells can make them, a statin alone often isn’t enough. You’re fighting an active antagonist in your bloodstream.

ApoE is a structural protein that sits on the outside of both LDL and HDL particles. It directs those particles to the right cells and organs. Different variants of APOE influence how efficiently your body removes LDL from circulation and how much HDL cholesterol you produce. Your APOE status is determined by two positions on the gene, creating three possible types: e2, e3, and e4.

The e4 variant is the cholesterol risk allele. Carried by roughly 25% of people with European ancestry, the e4 variant reduces your cells’ ability to clear LDL from your blood. If you’re e4/e4 (two copies of the e4 variant), your baseline LDL cholesterol tends to be significantly higher than e3/e3 carriers eating the same diet. The e4 variant also lowers HDL cholesterol, making your overall lipid profile less favorable.

Many people with young-onset high cholesterol carry the e4 variant. You’ll notice that your cholesterol stayed elevated even during periods when you ate very clean or trained hard. That’s the e4 effect. Your body’s baseline set point for cholesterol is simply higher than someone with e3/e3 or e2/e2. Your liver also produces cholesterol more aggressively when you carry e4, so dietary cholesterol reduction has a smaller effect than it would in e3 carriers.

Lipoprotein(a), or Lp(a), is a particle that’s similar to LDL cholesterol but behaves very differently. It carries cholesterol, but more importantly, it carries a protein called apolipoprotein(a) that makes it sticky and inflammatory. Lp(a) is almost entirely genetically determined. Your diet can barely move it. Your exercise habits don’t touch it. Your Lp(a) level is basically hard-wired from birth.

Roughly 20% of the population carries genetic variants that produce high Lp(a) levels. When your genes code for high Lp(a) production, you might have elevated Lp(a) circulating in your blood without having particularly high LDL cholesterol. High Lp(a) is an independent cardiovascular risk factor as strong as high LDL cholesterol, but standard cholesterol management often ignores it completely.

Here’s the trap: your doctor checks your total cholesterol and LDL cholesterol, sees acceptable numbers, and tells you everything is fine. Your Lp(a) is 50 mg/dL, 80 mg/dL, or higher. Lp(a) particles are accumulating in your artery walls. You’re at high cardiovascular risk from a particle that never makes it onto most lipid panels. Young people with high Lp(a) often go undiagnosed for years because doctors aren’t looking for it.

CETP is a protein that transfers cholesterol between different particles in your blood. It takes cholesterol-rich particles and moves cholesterol between HDL and LDL particles. In some cases, this is helpful. In others, it makes your LDL particles smaller and denser, which is worse for your arteries. Your CETP activity is controlled by genetic variants, particularly the TaqIB polymorphism and the I405V variant.

Roughly 40% of the population carries variants that reduce CETP activity. CETP-reducing variants can raise your HDL cholesterol significantly, which sounds good, but they often create a less favorable LDL particle composition with smaller, denser particles that penetrate artery walls more easily.

If you carry a CETP-reducing variant, you might have been told your HDL is excellent while your LDL is high. This combination actually masks a problem. Your particle composition is unfavorable despite decent HDL numbers. Diet changes and statins don’t directly address this particle-size issue. You might need a different approach entirely, focusing on reducing overall particle number rather than just chasing LDL numbers.